AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burgener, F.
Right arrow Articles by Hamlin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burgener, F.
Right arrow Articles by Hamlin, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 140, Issue 2, 291-295
Copyright © 1983 by American Roentgen Ray Society


Articles

Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques

FA Burgener and DJ Hamlin

Pre- and postcontrast CT scans of 125 nonselected patients with histologically verified hepatic neoplasms were analyzed. Sixty patients received an intravenous bolus injection of 50-100 ml diatrizoate 60% in 10-20 sec, and 65 patients an intravenous infusion of 300 ml diatrizoate 30% in 5-10 min. Compared to the precontrast examination, a significant improvement in the visualization of hepatic tumors was obtained with both contrast administration methods when the patients were examined before the equilibrium phase (difference in blood iodine concentration between aorta and inferior vena cava of less than 10 H) is reached. The equilibrium phase is reached 2 min after a contrast material bolus and with termination of an infusion. Scanning in the equilibrium phase does not significantly improve visualization of hepatic tumors when compared to the precontrast examination and carries a considerable risk of partial to complete tumor concealment. For similar reasons, concealment of hepatic tumors might also result when intravenous contrast material is used for another radiographic study preceding the CT examination.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
B. R. Herts, C. M. O'Malley, S. L. Wirth, M. L. Lieber, and B. Pohlman
Power Injection of Contrast Media Using Central Venous Catheters: Feasibility, Safety, and Efficacy
Am. J. Roentgenol., February 1, 2001; 176(2): 447 - 453.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Roentgen Ray Society.